The novel approach of tirzepatide peptide represents a significant development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – leading to enhanced sugar control and possible weight reduction. Experts are investigating its potential effects and